These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1425 related items for PubMed ID: 10408445

  • 1. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
    Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P.
    Nature; 1999 Jul 08; 400(6740):173-7. PubMed ID: 10408445
    [Abstract] [Full Text] [Related]

  • 2. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]

  • 3. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F.
    Nature; 1995 Feb 09; 373(6514):523-7. PubMed ID: 7845465
    [Abstract] [Full Text] [Related]

  • 4. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D.
    Nature; 1995 Feb 09; 408(6815):979-82. PubMed ID: 11140685
    [Abstract] [Full Text] [Related]

  • 5. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL.
    J Comp Neurol; 2003 Aug 04; 462(4):371-81. PubMed ID: 12811807
    [Abstract] [Full Text] [Related]

  • 6. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
    Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T.
    Nat Med; 2000 Aug 04; 6(8):916-9. PubMed ID: 10932230
    [Abstract] [Full Text] [Related]

  • 7. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS, Lamb BT.
    Neurobiol Dis; 2001 Dec 04; 8(6):982-92. PubMed ID: 11741394
    [Abstract] [Full Text] [Related]

  • 8. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA.
    J Neurochem; 2006 Mar 04; 96(5):1322-35. PubMed ID: 16478525
    [Abstract] [Full Text] [Related]

  • 9. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
    Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ.
    Ann Neurol; 2000 Oct 04; 48(4):567-79. PubMed ID: 11026440
    [Abstract] [Full Text] [Related]

  • 10. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
    Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML, Lee VM, Trojanowski JQ.
    J Comp Neurol; 1999 Aug 30; 411(3):390-8. PubMed ID: 10413774
    [Abstract] [Full Text] [Related]

  • 11. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L, Kurosinski P, Chen F, Tracy J, Mohajeri MH, Li H, Nitsch RM, Götz J.
    Neurobiol Dis; 2006 Apr 30; 22(1):50-6. PubMed ID: 16289870
    [Abstract] [Full Text] [Related]

  • 12. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug 30; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 13. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S.
    Neurobiol Aging; 2008 Feb 30; 29(2):241-52. PubMed ID: 17112635
    [Abstract] [Full Text] [Related]

  • 14. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
    Nemirovsky A, Shapiro J, Baron R, Kompaniets A, Monsonego A.
    J Neuroimmunol; 2012 Jun 15; 247(1-2):95-9. PubMed ID: 22498096
    [Abstract] [Full Text] [Related]

  • 15. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
    Lee M, Bard F, Johnson-Wood K, Lee C, Hu K, Griffith SG, Black RS, Schenk D, Seubert P.
    Ann Neurol; 2005 Sep 15; 58(3):430-5. PubMed ID: 16130106
    [Abstract] [Full Text] [Related]

  • 16. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 15; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 17. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ, Kulnane LS, Gao Y, Petriello MC, Pimpis KM, Younkin L, Dolios G, Wang R, Younkin SG, Lamb BT.
    Hum Mol Genet; 2003 Nov 15; 12(22):2949-56. PubMed ID: 14506131
    [Abstract] [Full Text] [Related]

  • 18. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA.
    Brain; 2008 Dec 15; 131(Pt 12):3299-310. PubMed ID: 18953056
    [Abstract] [Full Text] [Related]

  • 19. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J, Erb C, Ebert U, Baumann KH, Popp A, König G, Klein J.
    Neuroscience; 2004 Dec 15; 125(4):1009-17. PubMed ID: 15120860
    [Abstract] [Full Text] [Related]

  • 20. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW.
    Nature; 2004 Dec 15; 408(6815):982-5. PubMed ID: 11140686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.